DRUG DELIVERY
Vietnam·Risk Class TTBYT Loại A·XYLOBABY 0.025% SPRAY·INNOCEF Corporation·Registered Jul 22, 2024- Analysis ID
- 240001473/PCBA-HN
- Submission ID
- 000.00.19.H26-240719-0022
- Product Type
- XYLOBABY 0.025% SPRAY
- Manufacturer
- INNOCEF Corporation
- Manufacturer Country
- VIET NAM
- Product Owner
- HỘ KINH DOANH CƠ SỞ NGHIÊN CỨU VÀ PHÁT TRIỂN CÔNG NGHỆ DƯỢC PHẨM THIÊN NGUYÊN
- Authorized Representative
- HỘ KINH DOANH CƠ SỞ NGHIÊN CỨU VÀ PHÁT TRIỂN CÔNG NGHỆ DƯỢC PHẨM THIÊN NGUYÊN
- Intended Use
- -It gently helps to reduce the bacterial count in the nasal cavity, moisturizes, and reduces the irritation of the nasal mucosa in babies. -It helps to quickly relieve nasal congestion, providing a sense of relief. -It quickly and effectively alleviates the symptoms of nasal congestion and runny nose caused by the common cold, flu, chronic rhinitis, tonsillitis, otitis media, etc.
- Registration Date
- Jul 22, 2024
Companies providing products similar to "DRUG DELIVERY "
Recently registered similar products
Access comprehensive regulatory information for DRUG DELIVERY in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 240001473/PCBA-HN and manufactured by INNOCEF Corporation. The authorized representative in Vietnam is HỘ KINH DOANH CƠ SỞ NGHIÊN CỨU VÀ PHÁT TRIỂN CÔNG NGHỆ DƯỢC PHẨM THIÊN NGUYÊN.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including INNOCEF Corporation, and 3 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.